Because of a worldwide shortage of renal grafts, kidneys procured from donors after cardiac death (DCD) have recently become an important source of renal transplants. However, DCD kidneys often have complications with delayed graft function (DGF) and recipients require hemodialysis (HD) in the early period after kidney transplantation (KTx). This study evaluated serum NGAL as a potential specific parameter to predict early functional recovery of transplanted DCD kidneys. The average serum neutrophil gelatinase-associated lipocalin (NGAL) level in normal samples was 53 ± 30 ng/ml, while that in patients with chronic renal failure requiring HD was markedly raised at 963 ± 33 ng/ml. In patients undergoing a living-related KTx from a living donor (n = 11), serum NGAL level decreased rapidly after KTx, and only in two cases, with serum NGAL levels over 400 ng/ml on postoperative day 1 (POD1), was HD required due to DGF. In contrast, all patients undergoing a KTx from a DCD (n = 5) required HD due to DGF. Even in these cases, serum NGAL levels decreased rapidly several days after a KTx prior to the recovery of urine output and preceding the decrease in serum creatinine level. The pattern of decline in serum NGAL was biphasic, the decrease after the second peak indicating a functional recovery within the next several days. These data suggest that monitoring of serum NGAL levels may allow us to predict graft recovery and the need for HD after a KTx from a DCD.
INTRODUCTION
early posttransplant period (8). DGF predisposes the graft to both acute and chronic rejection (1, 7, 9, 14, (22) (23) (24) (25) 30) . Therefore, DGF is an independent risk factor for Because of a critical worldwide shortage of renal grafts, kidneys procured from deceased donors provid-suboptimal graft function at 1 year posttransplant. A variety of clinical parameters have been proposed ing a donation after cardiac death (DCD) have been recently recognized as an option in obtaining kidneys for for prediction of DGF based on preoperative risk factors (2,11), but no objective and reliable markers are cur-transplantation (KTx) (20, 28, 29) . However, in the early period after KTx, kidneys from DCD often require he-rently available for the early diagnosis of DGF following a KTx from a DCD. Several clinical definitions of modialysis (HD); this is known as a delayed graft function (DGF). A small percentage of the kidneys never DGF that employ urine output, creatinine reduction ratios, or HD requirement have been reported in the litera-recover their function, and they are referred to as primary nonfunction (8, 28) . DGF is fundamentally a clini-ture (1, 2, 7, 9, 11, 14, (22) (23) (24) (25) 30) . However, these clinical variables typically identify DGF only several days after cal manifestation of acute tubular necrosis (ATN), which is caused by warm ischemia of the graft after cardiac a KTx. A graft biopsy during the early period to identify findings of ATN and/or rejection or calcineurin inhibitor arrest in DCD. In addition to the common complications of KTx, such as acute rejection or calcineurin inhibitor nephrotoxicity is the only way to make a timely diagnosis of DGF in a KTx from a DCD. Novel specific bio-nephrotoxicity, DGF is an important problem during the markers to predict graft recovery of transplanted kidneys Serum samples were collected before and following KTx and stored in aliquots at −80°C. The primary out-during the anuric period after a KTx from a DCD are highly desirable. come variable was the development of DGF, defined as the need for HD within the first few weeks after trans-There is accumulating evidence that neutrophil gelatinase-associated lipocalin (NGAL) is as a sensitive plantation. The decision to initiate HD was taken by the primary transplant nephrologists and transplant surgeons, marker for the detection of kidney dysfunction. NGAL is one of the most remarkably upregulated genes in the without any involvement from the study investigators.
Other variables collected included age, gender, original kidney after ischemia (5, 18, 26) . In addition, NGAL is one of the genes rapidly induced in rat kidney isografts kidney disease, warm and total ischemic time, urine output, and serial serum creatinine. from brain-dead donors (12) . The expression of NGAL is induced in the proximal tubular epithelial cells during ELISA for NGAL Quantification the regeneration process after kidney injury (17, 18) . Importantly, NGAL is a highly predictive biomarker both
The ELISA for serum NGAL was performed as prefor acute and chronic kidney injury (3, 15, 19, 27 ). It has viously described (15) . Briefly, microtiter plates were prealso been suggested that urine NGAL level or immunocoated with a mouse monoclonal antibody raised against staining intensity of NGAL may serve as early biomarkhuman NGAL (HYB211-05, AntibodyShop, Gentofte, ers for renal injury after KTx (16, 21) . This study evalu-Denmark) and blocked with buffer containing 1% BSA. ates the usefulness of serum NGAL as a predictor of The wells were then coated with 100 µl of serum samgraft recovery after KTx from DCD. ples or standards (NGAL concentrations ranging from 1 to 1000 ng/ml), and incubated with a biotinylated mono-MATERIALS AND METHODS clonal antibody against human NGAL (HYB211-01B, Study Design AntibodyShop) followed by avidin-conjugated HRP (Dako, Carpinteria, CA, USA). TMB substrate (BD Bio-This investigation was approved by the Institutional sciences, San Jose, CA, USA) was added for color de-Review Boards of our centers. Written informed consent velopment, which was read after 30 min at 450 nm with was obtained from each patient or legal guardian before a microplate reader (Benchmark Plus, BioRad, Hercules, enrollment. Consecutive patients undergoing either a liv-CA, USA). All measurements were made in triplicate. ing-related (n = 11) or DCD KTx (n = 5) at this center
The inter-and intra-assay coefficient variations were 5were prospectively enrolled. The immunosuppressive 10% for batched samples analyzed on the same day. The regimen was similar in all patients, consisting of basilixlaboratory investigators were blinded to the sample imab, tacrolimus, or cyclosporine with prednisone and sources and clinical outcomes until the end of the study. mycophenolate mofetil.
The clinical characteristics of patients undergoing Statistical Analyses KTx from DCD are shown in Table 1 . All donors after
The results are expressed as the mean ± SEM. Statiscardiac death from this hospital were classified as type tical comparison between groups was performed by Stu-IV in this study. The cause of donor death was cerebrodent's t-test, and differences were considered to be sigvascular disease in all cases. Although all cases required nificant at p < 0.05. HD (5-22 days) after KTx because of DGF, the function of all of the transplanted kidneys eventually recovered. RESULTS There were no cases of rejection or calcineurin inhibitor nephrotoxicity, which were confirmed by a biopsy dur-Using this ELISA system, the average serum NGAL level in samples from healthy donors was 63 ng/ml (range ing DGF. 37-106 ng/ml). The normal control samples showed creatinine level gradually decreased during this period, which correlated reciprocally with a gradual increase in 21.4, 37.5, and 102.2 ng/ml (53 ± 30 ng/ml), which were within the reported normal range. In contrast, the aver-urine output (Fig. 2) . In contrast, the decrease of serum NGAL level in each patient generally followed a bipha-age serum NGAL level of the patients with chronic renal failure requiring HD was 963 ± 33 ng/ml (n = 138). sic pattern. The high level of NGAL prior to the KTx rapidly decreased within 5 days after the KTx, preceding First, serum NGAL levels of 11 patients who received a KTx from living donors were examined serially the decrease in creatinine. Thereafter, the NGAL levels demonstrated another increase during the DGF period before and after the KTx. Before the KTx, the serum NGAL concentration of the 11 cases ranged as high as between 7 and 10 days after the KTx. A decrease from the second peak started several days before the increase 750-1300 ng/ml. However, the serum NGAL concentration decreased dramatically in all cases as early as post-in urine output. The serum NGAL level at the last day of HD was below 500 ng/ml (mean 330 ng/ml) and then operative day 1 (POD1) after the KTx (Fig. 1) . Two out of 11 cases manifested DGF and required additional HD reached similar levels as those of who received a KTx from a living donor at 9 days after cessation of HD for 5 days after the KTx. One of these two DGF cases had a graft biopsy and the histological findings indicated (Fig. 2) . NGAL was retrospectively considered to be an indi-typical ATN. In these two cases, the serum NGAL level at POD1 was significantly higher than that in the other cator of recovery of graft function, providing a guide for the withdrawal of HD. In three cases (DCD 99, DCD nine cases (459 ± 27 vs. 213 ± 29 ng/ml, p < 0.01). In all cases, the serum NGAL reached a high normal level 101, and DCD 102), the serum NGAL levels decreased below 400 ng/ml several days before the final HD, but at POD2 and was stable thereafter.
Similarly, the serum NGAL levels of the five cases not in the remaining two cases (DCD 98 and DCD 100), who also recovered from DGF (Fig. 2) . Therefore, the that underwent a KTx from DCD were analyzed serially before and after the KTx. All the five cases that had serum concentration of NGAL alone was insufficient as an indicator of prognosis. On the other hand, the second DGF underwent graft biopsies, and the histological findings indicated typical ATN. Serum NGAL levels at peak of the biphasic decline of serum NGAL might be a good indicator of the functional recovery of grafts, POD1 were significantly higher than those from patients with a KTx from a living donor (Fig. 1) . Although the because all cases except for DCD 101 showed a rapid increase in urine output and loss of the requirement for function of the transplanted kidneys finally recovered in all these cases, they had a period of anuria after the KTx HD several days after the decrease from the second peak of serum NGAL (Fig. 2 ). due to DGF and required HD (5-22 days). The serum 
DISCUSSION
cellent renal function and good long-term graft survival, the mean duration of posttransplant HD at our center was still about 2 weeks (10,13). This situation, particular In addition to the critical shortage of renal allografts, legal and ethical problems preclude brain-dead organ to Japan, prompted the need for highly sensitive prognostic marker for DGF in KTx from DCDs. donation in Japan. Therefore, most of the cadaveric kidneys used over the past 3 decades in Japan have been This study evaluated the usefulness of serum NGAL as a predictor of graft recovery after a KTx, particularly derived from DCDs. Since April 1979, 477 kidneys were retrieved from DCDs at this center alone, thus rep-a KTx from DCD. The results strongly suggest that the serum NGAL level at POD1 predicts graft dysfunction resenting approximately 10% of all kidneys procured in Japan. These kidneys were then often transplanted under in patients who received a KTx from a living donor. In patients receiving a KTx from a DCD, the decrease in suboptimal conditions. Approximately 40% of kidney grafts were derived from expanded criteria donors (10, the serum NGAL manifested a biphasic curve. This suggests that the decrease from the second peak may predict 13). The DCDs from this hospital were classified mainly as type IV category donors, but mostly from the recently the recovery of organ function and the optimal timing for weaning of HD within the next several days. In com-categorized "uncontrolled" DCD (4,6). Further, these patients had been waiting for a KTx for many years. All parison to the changes in serum NGAL level, the changes in serum creatinine level appeared to display lower cor-recipients who received a KTx from a DCD in this study had required HD for at least 10 years. Under these con-relation with graft recovery in each patient. The serum or urine NGAL levels have previously been reported to ditions for both donors and recipients, there was a high incidence of DGF and a prolonged period of ATN. Al-have an advantage over the serum creatinine level in predicting acute renal injury because of its rapid re-though an in situ regional cooling technique allows ex-sponse to changes in the kidney function (15, 27) . The NGAL changes, the urine output began to increase and all grafts recovered. It is still unclear as to why the se-present data lend support to this argument.
The immunostaining of NGAL has been reported to rum NGAL level decreased prior to the recovery of the urine volume. Is NGAL a rapid turnover protein that is be is a potential biomarker for recovery of kidney function after a KTx (16) . A 1-h biopsy, the only established not affected by clearance from the kidney? Or does the switch of blood flow from the native kidney to the graft diagnostic tool, allows the sampling of kidney tissue by a routine biopsy after a KTx. However, repeated biopsy affect the NGAL level? The kinetics of NGAL in kidneys undergoing KTx deserve further investigation. would be an invasive and stressful procedure for patients. Urine may be a useful alternative and noninvasive
In summary, although the number of patients in this study was small, the present findings identified the se-source for diagnostic samples. The urine NGAL has been recently reported to be a predictive biomarker for rum NGAL levels to be a prime candidate for predicting organ recovery after a KTx, especially for a KTx from DGF (21). However, because prognostic biomarkers are required for patients in the anuric period of DGF that is a DCD. often observed after a KTx from a DCD, urine NGAL REFERENCES is of limited usefulness as an early biomarker of graft course, and graft recovery in each case. After these
